CANADA LIFE ASSURANCE Co Increases Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

CANADA LIFE ASSURANCE Co boosted its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 14.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 212,681 shares of the medical instruments supplier's stock after acquiring an additional 27,246 shares during the period. CANADA LIFE ASSURANCE Co owned 0.11% of DENTSPLY SIRONA worth $4,034,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the company. Treasurer of the State of North Carolina raised its position in DENTSPLY SIRONA by 0.6% during the fourth quarter. Treasurer of the State of North Carolina now owns 88,854 shares of the medical instruments supplier's stock valued at $1,686,000 after purchasing an additional 560 shares in the last quarter. UMB Bank n.a. lifted its position in DENTSPLY SIRONA by 60.8% in the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock worth $28,000 after buying an additional 564 shares during the last quarter. Blue Trust Inc. boosted its stake in shares of DENTSPLY SIRONA by 10.9% in the 4th quarter. Blue Trust Inc. now owns 7,199 shares of the medical instruments supplier's stock valued at $137,000 after purchasing an additional 707 shares in the last quarter. Federated Hermes Inc. grew its holdings in shares of DENTSPLY SIRONA by 0.5% during the 4th quarter. Federated Hermes Inc. now owns 169,304 shares of the medical instruments supplier's stock valued at $3,213,000 after purchasing an additional 915 shares during the last quarter. Finally, Covestor Ltd raised its position in DENTSPLY SIRONA by 14.9% in the 4th quarter. Covestor Ltd now owns 8,322 shares of the medical instruments supplier's stock worth $158,000 after purchasing an additional 1,081 shares during the period. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Stock Down 0.4 %

DENTSPLY SIRONA stock traded down $0.05 on Wednesday, hitting $13.90. 3,680,447 shares of the stock traded hands, compared to its average volume of 2,976,561. DENTSPLY SIRONA Inc. has a 1 year low of $12.16 and a 1 year high of $30.78. The firm has a market cap of $2.77 billion, a P/E ratio of -6.71, a price-to-earnings-growth ratio of 1.80 and a beta of 0.92. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The business's fifty day simple moving average is $14.79 and its 200 day simple moving average is $18.11.

DENTSPLY SIRONA Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, April 11th. Stockholders of record on Friday, March 28th were issued a dividend of $0.16 per share. The ex-dividend date was Friday, March 28th. This represents a $0.64 annualized dividend and a dividend yield of 4.60%. DENTSPLY SIRONA's payout ratio is -14.07%.

Insider Transactions at DENTSPLY SIRONA

In other news, Director Gregory T. Lucier acquired 15,142 shares of DENTSPLY SIRONA stock in a transaction on Monday, March 3rd. The stock was acquired at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the purchase, the director now owns 81,971 shares in the company, valued at $1,353,341.21. This trade represents a 22.66 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.52% of the company's stock.

Analyst Ratings Changes

Several research analysts have recently commented on XRAY shares. Robert W. Baird decreased their price objective on DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating on the stock in a report on Friday, February 28th. Needham & Company LLC reissued a "hold" rating on shares of DENTSPLY SIRONA in a research note on Thursday, March 13th. Morgan Stanley downgraded shares of DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 target price on the stock. in a research note on Tuesday, April 15th. Jefferies Financial Group cut shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating and dropped their price target for the company from $30.00 to $20.00 in a research report on Thursday, January 23rd. Finally, Evercore ISI reaffirmed an "in-line" rating and set a $20.00 price objective on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. Thirteen investment analysts have rated the stock with a hold rating and two have given a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $21.25.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.